Listeria Monocytogenes Clinical Trial
Official title:
Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester of Pregnancy: a Case Report and Review of Literatures
NCT number | NCT03248973 |
Other study ID # | 106030-C |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 3, 2017 |
Est. completion date | February 2, 2018 |
Verified date | February 2019 |
Source | Far Eastern Memorial Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester of Pregnancy
Status | Completed |
Enrollment | 1 |
Est. completion date | February 2, 2018 |
Est. primary completion date | January 8, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - One pregnant woman with listeria monocytogenes bacteremia in the first trimester |
Country | Name | City | State |
---|---|---|---|
Taiwan | Far Eastern Memorial Hospital | New Taipei |
Lead Sponsor | Collaborator |
---|---|
Far Eastern Memorial Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Successful treatment | A favorable outcome of maternal listeria infection in the first trimester may be anticipated. Besides, intravenous ampicillin with or without gentamicin should be a reasonable treatment option for maternal listeria infection in the first trimester. | 1 month after delivery |